July 08, 2024 at 10:56 am

Annovis Bio Shares Soar on New Phase 3 Data in Parkinson’s Disease

Shares in late-stage clinical drug platform company Annovis Bio (Nasdaq: ANVS) soared nearly 40% on Friday after the company announced new data from its Phase 3 Parkinson’s disease study. The study has demonstrated that buntanetap is safe and effective in improving motor and non-motor activities and improving cognitive functions in patients with early Parkinson’s disease…. [Read More]
July 05, 2024 at 9:11 am

Purple Biotech Reports Positive Data from Pancreatic Cancer Study

Clinical-stage biotechnology company, Purple Biotech (Nasdaq: PPBT) has reported additional positive interim data from its randomized, controlled, open label, multicenter Phase 2 study of CM24, in combination with nivolumab and standard of care (SoC) chemotherapy, in second-line metastatic pancreatic ductal adenocarcinoma (PDAC). Further data and top line results are expected in the second half of… [Read More]
July 03, 2024 at 9:12 am

NLS Pharmaceutics Offers Preclinical Hope for Parkinson’s Disease Treatment

Shares in Swiss biopharmaceutical company, NLS Pharmaceutics (Nasdaq: NLSP), soared more than 50% in trading after the company announced positive preclinical results from multiple in vitro studies of three compounds, demonstrating their potential to advance the treatment of Parkinson’s Disease (PD). In NLS’ studies, the compounds showed positive effects on neurite outgrowth, a critical parameter… [Read More]
July 02, 2024 at 4:59 pm

S&P 500 Surpasses 5,500 in Historic Rally: Market Overview

In an unprecedented surge, the S&P 500 closed above the 5,500 mark for the first time, marking a historic milestone in a year that has already seen the index hit 32 record highs. This rally is part of a broader bullish trend in 2024, fueled by solid corporate earnings, enthusiasm over artificial intelligence, and anticipations… [Read More]
July 02, 2024 at 12:37 pm

Stocks making the biggest midday moves: Tesla, Polestar, Paramount Global and more

Don’t miss out on the companies making a splash in the world of midday trading! Tesla Tesla sees a near 9% surge following a robust second-quarter delivery report which surpassed expectations. Despite showing a 4.8% dip from last year, the Elon Musk-led firm’s delivery of 443,956 vehicles outshone the projected delivery of 439,000 by analysts… [Read More]
July 02, 2024 at 9:14 am

Oragenics to Develop Device to Treat Concussion

Pharmaceuticals company, Oragenics (NYSE American: OGEN), has completed a prototype of an automated intranasal device for use in concussed patients who are initially confused, dazed or unconscious in the acute phase of injury. Oragenics’ lead drug candidate, ONP-002, is a new chemical entity (NCE) designed to target the brain through delivery into the nasal cavity… [Read More]
July 02, 2024 at 8:51 am

Stocks making the biggest moves premarket: Tesla, CrowdStrike, Paramount Global, Atlassian and more

Take a look at the key players making waves during premarket trading. Tesla – This electric vehicle player saw a 1.5% drop before the bell, despite a remarkable 6% surge during Monday’s session. The company is expected to release second-quarter delivery data on Tuesday morning, which could influence the stock’s performance. Atlassian Corporation — With… [Read More]